Certara to Participate in the Stephens Annual Investment Conference

RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the Stephens Annual Investment Conference.

Company management will present at 10:00AM CT on Thursday, November 21^st, 2024.

A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]

Media Contact:
Alyssa Horowitz
[email protected]

You May Also Be Interested In

• Anmodning om ophør af suspension i enkelte afdelinger under Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select
• WeRide Recognized on Fortune's 2026 Change the World List as the Only Autonomous Driving Company Honored
• Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress